Academic Journals Database
Disseminating quality controlled scientific knowledge

Neuropsychiatric effects of tenofovir in comparison with other antiretroviral drugs

Author(s): Ferrer K | Rakhmanina N

Journal: Neurobehavioral HIV Medicine
ISSN 1179-1497

Volume: 2013;
Issue: default;
Start page: 1;
Date: 2013;
Original page

Kathleen Ferrer,1,2 Natella Rakhmanina1,21Department of Pediatrics, George Washington University School of Medicine, Washington, DC, USA; 2Health Sciences Children's National Medical Center, Washington, DC, USAAbstract: Tenofovir is a widely used antiretroviral medication indicated to treat adults and children infected with HIV. Current guidelines for the management of HIV infection recommend tenofovir disoproxil fumarate (TDF) as a component of the preferred first-line combination antiretroviral therapy. The efficacy, tolerability, prolonged half-life allowing for once-daily administration, and availability as a component of several fixed-dose formulations make TDF an attractive choice for treatment-naive and treatment-experienced HIV-infected patients. TDF is also widely used as a component of postexposure prophylaxis in noninfected individuals. Most importantly, it has been recently approved for use as pre-exposure prophylaxis for noninfected adults and adolescents to reduce the risk of HIV transmission. With increasing use of TDF among adults and children, understanding of the potential for drug-associated side effects is important. This review focuses on the neuropsychiatric effects of tenofovir in adults and children with HIV infection in comparison with other antiretroviral drugs.Keywords: HIV, tenofovir, neuropsychiatric effects
RPA Switzerland

RPA Switzerland

Robotic process automation


Tango Jona
Tangokurs Rapperswil-Jona